Public Health Implications: Translation into Diabetes Prevention Initiatives-Four-Level Public Health Concept

Medical Clinics of North America

Volumn 95, Issue 2, 2011, Pages 397-407

  Schwarz, Peter E H ^a  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

Diabetes prevention; Implementation; Public health policy; Toolkit

Indexed keywords

BEHAVIOR CHANGE; CARDIOVASCULAR RISK; CLINICAL PRACTICE; COST EFFECTIVENESS ANALYSIS; HEALTH BEHAVIOR; HUMAN; LIFESTYLE MODIFICATION; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PRACTICE GUIDELINE; PRIMARY PREVENTION; PRIORITY JOURNAL; PUBLIC HEALTH; REVIEW; RISK REDUCTION; SCREENING; WAIST CIRCUMFERENCE; WEIGHT REDUCTION;

BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; GLUCOSE INTOLERANCE; HEALTH POLICY; HUMANS; PATIENT EDUCATION AS TOPIC; PUBLIC HEALTH ADMINISTRATION; QUALITY INDICATORS, HEALTH CARE; WORLD HEALTH;

EID: 79251553482     PISSN: 00257125     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mcna.2010.11.008     Document Type: Review

References (38)

1. Zimmet P., Alberti K.G., Shaw J. Global and societal implications of the diabetes epidemic. Nature 2001, 414(6865):782-787.
2. Zimmet P., Shaw J., Alberti K.G. Preventing type 2 diabetes and the dysmetabolic syndrome in the real world: a realistic view. Diabet Med 2003, 20(9):693-702.
3. Nestle M. Preventing childhood diabetes: the need for public health intervention. Am J Public Health 2005, 95(9):1497-1499.
4. Knowler W.C., Barrett-Connor E., Fowler S.E., et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002, 346(6):393-403.
5. Tuomilehto J., Lindström J., Eriksson J.G., et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001, 344(18):1343-1350.
6. Chiasson J.L., Josse R.G., Gomis R., et al. Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. Lancet 2002, 359(9323):2072-2077.
7. Pan X.R., Li G.W., Hu Y.H., et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care 1997, 20(4):537-544.
8. Torgerson J.S., Hauptman J., Boldrin M.N., et al. XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care 2004, 27(1):155-161.
9. Hernan W.H., Brandle M., Zhang P., et al. Costs associated with the primary prevention of type 2 diabetes mellitus in the diabetes prevention program. Diabetes Care 2003, 26(1):36-47.
10. Schwarz P.E., Schwarz J., Schuppenies A., et al. Development of a diabetes prevention management program for clinical practice. Public Health Rep 2007, 122(2):258-263.
11. Ackermann R.T., Marrero D.G. Adapting the Diabetes Prevention Program lifestyle intervention for delivery in the community: the YMCA model. Diabetes Educ 2007, 33(1):69. 74-5, 77-8.
12. Tuomilehto J., Schwarz P.E. Primary prevention of type 2 diabetes is advancing towards the mature stage in Europe. Horm Metab Res 2010, 42(Suppl 1):1-2.
13. Rothe U., Müller G., Schwarz P.E., et al. Evaluation of a diabetes management system based on practice guidelines, integrated care, and continuous quality management in a Federal State of Germany: a population-based approach to health care research. Diabetes Care 2008, 31(5):863-868.
14. Schwarz P.E., Greaves C., Reddy P., et al. Diabetes prevention in practice 2010, vol. 1. TUMAINI Institute for Prevention management, Dresden (Germany), p. 232.
15. Schwarz P.E., Lindström J., Kissimova-Scarbeck K., et al. The European perspective of type 2 diabetes prevention: diabetes in Europe-prevention using lifestyle, physical activity and nutritional intervention (DE-PLAN) project. Exp Clin Endocrinol Diabetes 2008, 116(3):167-172.
16. Makrilakis K., Liatis S., Grammatikou S., et al. Implementation and effectiveness of the first community lifestyle intervention programme to prevent type 2 diabetes in Greece. The DE-PLAN study. Diabet Med 2010, 27(4):459-465.
17. O'Gorman D.J., Krook A. Exercise and the treatment of diabetes and obesity. Endocrinol Metab Clin North Am 2008, 37(4):887-903.
18. Schwarz P.E., Gruhl U., Bornstein S.R., et al. The European Perspective on Diabetes Prevention: development and Implementation of a European Guideline and training standards for diabetes prevention (IMAGE). Diab Vasc Dis Res 2007, 4(4):353-357.
19. Pajunen P., Landgraf R., Muylle F., et al. Quality indicators for the prevention of type 2 diabetes in Europe-IMAGE. Horm Metab Res 2010, 42(Suppl 1):S56-S63.
20. Schwarz P.E., Li J., Lindstrom J., et al. Tools for predicting the risk of type 2 diabetes in daily practice. Horm Metab Res 2009, 41(2):86-97.
21. Inzucchi S.E., Sherwin R.S. The prevention of type 2 diabetes mellitus. Endocrinol Metab Clin North Am 2005, 34(1):199-219. viii.
22. Al-Lawati J.A., Tuomilehto J. Diabetes risk score in Oman: a tool to identify prevalent type 2 diabetes among Arabs of the Middle East. Diabetes Res Clin Pract 2007, 77(3):438-444.
23. Rathmann W., Martin S., Haastert B., et al. Performance of screening questionnaires and risk scores for undiagnosed diabetes: the KORA Survey 2000. Arch Intern Med 2005, 165(4):436-441.
24. Schwarz P.E., Li J., Reimann M., et al. The finnish diabetes risk score is associated with insulin resistance and progression towards type 2 diabetes. J Clin Endocrinol Metab 2009, 94(3):920-926.
25. Glumer C., Vistisen D., Borch-Johnsen K., et al. Risk scores for type 2 diabetes can be applied in some populations but not all. Diabetes Care 2006, 29(2):410-414.
26. Ramachandran A., Moses A., Shetty S., et al. A new non-invasive technology to screen for dysglycaemia including diabetes. Diabetes Res Clin Pract 2010, 88:302-306.
27. Ziemer D.C., Kolm P., Weintraub W.S., et al. Glucose-independent, black-white differences in hemoglobin A1c levels: a cross-sectional analysis of 2 studies. Ann Intern Med 2010, 152(12):770-777.
28. Bergman M. Inadequacies of absolute threshold levels for diagnosing prediabetes. Diabetes Metab Res Rev 2010, 26(1):3-6.
29. Abdul-Ghani M.A., Lyssenko V., Tuomi T., et al. Fasting versus postload plasma glucose concentration and the risk for future type 2 diabetes: results from the Botnia Study. Diabetes Care 2009, 32(2):281-286.
30. Schwarz P.E., Muylle F., Valensi P., et al. The European perspective of diabetes prevention. Horm Metab Res 2008, 40(8):511-514.
31. Paulweber B., Valensi P., Lindström J., et al. A European evidence-based guideline for the prevention of type 2 diabetes. Horm Metab Res 2010, 42(Suppl 1):S3-S36.
32. Lindstrom J., Neumann A., Sheppard K.E., et al. Take action to prevent diabetes-the IMAGE toolkit for the prevention of type 2 diabetes in Europe. Horm Metab Res 2010, 42(Suppl 1):S37-S55.
33. Saaristo T., Peltonen M., Keinänen-Kiukaanniemi S., et al. National type 2 diabetes prevention programme in Finland: FIN-D2D. Int J Circumpolar Health 2007, 66(2):101-112.
34. Absetz P., Valve R., Oldenburg B., et al. Type 2 diabetes prevention in the " real world": one-year results of the GOAL implementation trial. Diabetes Care 2007, 30(10):2465-2470.
35. Ackermann R.T., Finch E.A., Brizendine E., et al. Translating the Diabetes Prevention Program into the community. The DEPLOY Pilot Study. Am J Prev Med 2008, 35(4):357-363.
36. Lipscomb E.R., Finch E.A., Brizendine E., et al. Reduced 10-year risk of coronary heart disease in patients who participated in a community-based diabetes prevention program: the DEPLOY pilot study. Diabetes Care 2009, 32(3):394-396.
37. Yates T., Davies M., Gorely T., et al. Effectiveness of a pragmatic education program designed to promote walking activity in individuals with impaired glucose tolerance: a randomized controlled trial. Diabetes Care 2009, 32(8):1404-1410.
38. Yates T., Davies M., Gorely T., et al. Rationale, design and baseline data from the Pre-diabetes Risk Education and Physical Activity Recommendation and Encouragement (PREPARE) programme study: a randomized controlled trial. Patient Educ Couns 2008, 73(2):264-271.